Hirohisa Kano

7PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 13, 2026
Discrepant Intracranial and Extracranial Responses to Tarlatamab in Relapsed Small-Cell Lung Cancer With Untreated Brain Metastases: A Case Report.

|Dec 17, 2024
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.

Masataka Taoka, Eiki Ichihara, Toshihide Yokoyama

|Sep 15, 2023
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.

Chihiro Ando, Eiki Ichihara, Tatsuya Nishi

|Dec 23, 2022
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study.

Tomoka Nishimura, Eiki Ichihara, Toshihide Yokoyama

|Jul 08, 2022
CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer.

Kazuya Nishii, Kadoaki Ohashi, Shuta Tomida

|Jan 07, 2021
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani

Pageof 2

Frequent Collaborators

6 joint publications

Eiki Ichihara

3 joint publications

Katsuyuki Hotta

3 joint publications

Go Makimoto

3 joint publications

Kadoaki Ohashi